Latest issue of Hampshire & IOW Medicines Optimisation Bulletin

Tha latest bulletin contains information on the following:

• DHSC: UPDATED National Patient Safety Alert: Discontinuation of Kay-Cee-L (potassium chloride 375mg/ml) (potassium chloride 5mmol/5ml) syrup
• Insulin pumps and continuous glucose monitoring (CGM) equipment: guidance for users on reporting suspected adverse incidents and safety concerns to the MHRA’s Yellow Card scheme
• GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse
• Direct healthcare professional communication: Medroxyprogesterone acetate: risk of meningioma and measures to minimise this risk
• HIOW ICB Cinacalcet shared care guideline
• Drospirenone (Slynd®) – new addition to the formulary
• DHSC: Extension to temporary ban on puberty blockers
• UK HSA: Meningococcal disease: guidance on public health management – update
• Menopause: identification and management - updated guidance (NG23)
• Endometriosis: diagnosis and management – updated guidance (NG73)

Bulletin 109 and all previous Bulletins can be accessed via our website:  Bulletin :: NHS Hampshire and Isle of Wight